Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 15
1979 22
1980 10
1981 9
1982 8
1983 9
1984 16
1985 11
1986 16
1987 9
1988 10
1989 10
1990 12
1991 6
1992 8
1993 4
1994 8
1995 7
1996 10
1997 14
1998 12
1999 21
2000 21
2001 18
2002 14
2003 16
2004 30
2005 18
2006 21
2007 14
2008 16
2009 5
2010 10
2011 15
2012 9
2013 8
2014 2
2015 3
2016 4
2017 5
2018 1
2019 2
2020 1
2021 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

469 results

Results by year

Filters applied: . Clear all
Page 1
Anastrozole.
Kelly CM, Buzdar AU. Kelly CM, et al. Among authors: buzdar au. Expert Opin Drug Saf. 2010 Nov;9(6):995-1003. doi: 10.1517/14740338.2010.515977. Expert Opin Drug Saf. 2010. PMID: 20923259 Review.
Molecular Characterization and Prospective Evaluation of Pathologic Response and Outcomes with Neoadjuvant Therapy in Metaplastic Triple-Negative Breast Cancer.
Yam C, Abuhadra N, Sun R, Adrada BE, Ding QQ, White JB, Ravenberg EE, Clayborn AR, Valero V, Tripathy D, Damodaran S, Arun BK, Litton JK, Ueno NT, Murthy RK, Lim B, Baez L, Li X, Buzdar AU, Hortobagyi GN, Thompson AM, Mittendorf EA, Rauch GM, Candelaria RP, Huo L, Moulder SL, Chang JT. Yam C, et al. Among authors: buzdar au. Clin Cancer Res. 2022 Jul 1;28(13):2878-2889. doi: 10.1158/1078-0432.CCR-21-3100. Clin Cancer Res. 2022. PMID: 35507014 Free PMC article. Clinical Trial.
Long-Term Prognostic Risk After Neoadjuvant Chemotherapy Associated With Residual Cancer Burden and Breast Cancer Subtype.
Symmans WF, Wei C, Gould R, Yu X, Zhang Y, Liu M, Walls A, Bousamra A, Ramineni M, Sinn B, Hunt K, Buchholz TA, Valero V, Buzdar AU, Yang W, Brewster AM, Moulder S, Pusztai L, Hatzis C, Hortobagyi GN. Symmans WF, et al. Among authors: buzdar au. J Clin Oncol. 2017 Apr 1;35(10):1049-1060. doi: 10.1200/JCO.2015.63.1010. Epub 2017 Jan 30. J Clin Oncol. 2017. PMID: 28135148 Free PMC article.
Evolving novel anti-HER2 strategies.
Jones KL, Buzdar AU. Jones KL, et al. Among authors: buzdar au. Lancet Oncol. 2009 Dec;10(12):1179-87. doi: 10.1016/S1470-2045(09)70315-8. Lancet Oncol. 2009. PMID: 19959074 Review.
Breast cancer in men.
Giordano SH, Buzdar AU, Hortobagyi GN. Giordano SH, et al. Among authors: buzdar au. Ann Intern Med. 2002 Oct 15;137(8):678-87. doi: 10.7326/0003-4819-137-8-200210150-00013. Ann Intern Med. 2002. PMID: 12379069 Review.
Making genuine progress against metastatic breast cancer.
Lyman GH, Burstein HJ, Buzdar AU, D'Agostino R, Ellis PA. Lyman GH, et al. Among authors: buzdar au. J Clin Oncol. 2012 Oct 1;30(28):3448-51. doi: 10.1200/JCO.2012.43.6931. Epub 2012 Aug 27. J Clin Oncol. 2012. PMID: 22927527 Review. No abstract available.
Inflammatory breast cancer: a review.
Jaiyesimi IA, Buzdar AU, Hortobagyi G. Jaiyesimi IA, et al. Among authors: buzdar au. J Clin Oncol. 1992 Jun;10(6):1014-24. doi: 10.1200/JCO.1992.10.6.1014. J Clin Oncol. 1992. PMID: 1588366 Review.
Management of inflammatory breast cancer.
Singletary SE, Ames FC, Buzdar AU. Singletary SE, et al. Among authors: buzdar au. World J Surg. 1994 Jan-Feb;18(1):87-92. doi: 10.1007/BF00348197. World J Surg. 1994. PMID: 8197782 Review.
Locally advanced noninflammatory breast cancer.
Hunt KK, Ames FC, Singletary SE, Buzdar AU, Hortobagyi GN. Hunt KK, et al. Among authors: buzdar au. Surg Clin North Am. 1996 Apr;76(2):393-410. doi: 10.1016/s0039-6109(05)70446-1. Surg Clin North Am. 1996. PMID: 8610271 Review.
469 results